ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
信息服務
4.90
+0.1037
2.16%
成交量:
2.81萬
成交額:
13.71萬
市值:
2.36億
市盈率:
31.32
高:
4.97
開:
4.83
低:
4.83
收:
4.80
資料載入中...
總覽
公司
新聞
公告
百利天恆(688506.SH)注射用BL-M07D1(HER2-ADC)獲II/III期臨牀試驗批准通知書
智通财经
·
02-18
上海凱寶:截至目前優欣定項目處於III期臨牀研究階段
互动易
·
02-18
mRNA巨頭:2024業績下降 66%,III期研究被暫停
生物药大时代
·
02-18
諾誠健華現漲逾10% ICP-248聯合療法III期臨牀試驗獲國家藥監局批准
新浪港股
·
02-18
江蘇長泰藥業股份有限公司申請III類會議
金融界
·
02-18
大連美羅中藥廠有限公司申請III類會議
金融界
·
02-18
無錫朗潤醫藥有限公司申請III類會議
金融界
·
02-18
DeepSeek最新動作曝光,經營範圍新增互聯網信息服務!下一步向C端應用生態延伸?
金融界
·
02-17
諾誠健華(09969):BCL2抑制劑ICP-248(Mesutoclax)聯合奧布替尼用於一線CLL╱SLL患者治療的III期註冊研究在中國獲批
智通财经
·
02-17
DeepSeek新增互聯網信息服務
Odaily
·
02-17
諾誠健華獲批啓動ICP-248聯合療法III期臨牀試驗
财中社
·
02-17
佛山市隆信醫藥科技有限公司申請III類會議
金融界
·
02-17
DeepSeek母公司主要人員變更,經營範圍擴大
美港电讯
·
02-17
【瀘天化:硝酸車間III硝裝置180天超長週期運行】 據瀘天化消息,自2024年8月19日19時05分開車以來,公司硝酸車間III硝裝置已連續平穩運行180天,累計生產硝酸6.8萬噸,創造了硝酸車間2025年首個長週期運行記錄。
金融界
·
02-15
【甘李藥業胰島素周製劑GZR4注射液中國2型糖尿病III期臨牀研究SUPER-2完成首例受試者給藥】 甘李藥業股份有限公司宣佈公司自主研發的基礎胰島素周製劑GZR4注射液在中國既往接受過基礎胰島素治療的2型糖尿病受試者中的開展的一項大規模III期臨牀研究完成首例受試者給藥,這也是甘李藥業啓動的GZR4注射液全球首項III期臨牀研究。
金融界
·
02-15
山東步長製藥股份有限公司申請III類會議
金融界
·
02-15
百時美施貴寶PD-1+LAG-3組合療法一項III期研究失敗
医药魔方Info
·
02-14
金融信息服務巨頭,也來做VC了
每日经济新闻
·
02-13
智翔金泰(688443.SH)GR1802注射液啓動慢性自發性蕁麻疹適應症III期臨牀試驗
智通财经
·
02-13
智翔金泰:GR1802注射液啓動慢性自發性蕁麻疹III期臨牀試驗
美港电讯
·
02-13
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/III/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服務","latestPrice":4.9037,"timestamp":1747402702349,"preClose":4.8,"halted":0,"volume":28065,"delay":0,"floatShares":34401437,"shares":48204172,"eps":0.156567,"marketStatus":"交易中","change":0.1037,"latestTime":"05-16 09:40:32 EDT","open":4.83,"high":4.97,"low":4.83,"amount":137128.84554,"amplitude":0.029167,"askPrice":4.92,"askSize":101,"bidPrice":4.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.156567,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1747425600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":4.8,"dividendRate":0.036707,"preHourTrading":{"tag":"盘前","latestPrice":4.9992,"preClose":4.8,"latestTime":"09:17 EDT","volume":3,"amount":14.9976,"timestamp":1747401470890},"postHourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.8,"latestTime":"18:43 EDT","volume":1024,"amount":4916.88,"timestamp":1747349010587},"volumeRatio":2.499647,"impliedVol":1.0587,"impliedVolPercentile":0.508},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34401437,"roa":"3.30%","roe":"8.09%","lyrEps":0.058194,"volumeRatio":2.499647,"shares":48204172,"dividePrice":0.18,"high":4.97,"amplitude":0.029167,"preClose":4.8,"low":4.83,"week52Low":2.92,"pbRate":"2.49","psRate":"0.97","week52High":4.98,"institutionHeld":0.6217,"latestPrice":4.9037,"committee":-0.004975,"eps":0.156567,"divideRate":0.036707,"volume":28065,"delay":0,"ttmEps":0.156567,"open":4.83,"prevYearClose":3.34,"prevWeekClose":4.64,"prevMonthClose":3.88,"prevQuarterClose":3.91,"fiveDayClose":4.64,"twentyDayClose":3.72,"sixtyDayClose":3.1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512163139","title":"百利天恆(688506.SH)注射用BL-M07D1(HER2-ADC)獲II/III期臨牀試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2512163139","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512163139?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 17:04","pubTimestamp":1739869479,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百利天恒 公告,公司于近日收到国家药品监督管理局正式批准签发的《药物临床试验批准通知书》,公司自主研发的创新生物药注射用BL-M07D1的II/III期临床试验获得批准。据悉,BL-M07D1是一种靶向HER2的创新ADC,具有best-in-class潜力,已在临床试验中展示出显著的抗肿瘤功效。截至本公告披露日,除本次新获得批准的临床试验外,BL-M07D1正于中国及美国的10项I/II/III期临床试验中作为单药或联用进行评估。各项临床研究包括各种HER2表达/突变的实体瘤的患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BL","BK4080","BK0239","BK4023","BK1141","BK4134","LU0757428866.USD","LU1815336091.USD","ADC","03347","BK4231","688506","BK1583","III","BK1576"],"gpt_icon":0},{"id":"2512182341","title":"上海凱寶:截至目前優欣定項目處於III期臨牀研究階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2512182341","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512182341?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 12:09","pubTimestamp":1739851740,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 有投资者向上海凯宝提问, 请问贵公司的优欣定开发的最近进度到哪里了??公司回答表示,投资者您好,截至目前优欣定项目处于III期临床研究阶段。后续达到披露节点将及时予以公告。感谢您的关注!\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-18/doc-inekwqmn6824696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["III","BK0239","BK0188","BK4134","300039","BK0028"],"gpt_icon":0},{"id":"2512933185","title":"mRNA巨頭:2024業績下降 66%,III期研究被暫停","url":"https://stock-news.laohu8.com/highlight/detail?id=2512933185","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512933185?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 11:15","pubTimestamp":1739848519,"startTime":"0","endTime":"0","summary":"近日,Moderna公布2024年财报:全年营收32.36亿美元,同比下降53%;;其中Q4收入9.66亿美元,同比下降 66%。另外,Moderna已提交三款mRNA实验性产品的上市申请,包括下一代新冠疫苗、针对18至59岁高风险成年人的RSV疫苗,以及流感/新冠联合疫苗。Moderna预计2025年总收入在15亿到25亿美元之间,同比下降33%。同时,Moderna还宣布,由于出现一例格林-巴利综合征,FDA已暂停其诺如病毒候选疫苗的III期研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218131551a24a132f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218131551a24a132f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","MRNA","III","BK4551","BK4585","BK4134","BK4532","BK4568","BK4534","BK4588","BK4139","BK4533","BK4501"],"gpt_icon":1},{"id":"2512271909","title":"諾誠健華現漲逾10% ICP-248聯合療法III期臨牀試驗獲國家藥監局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2512271909","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512271909?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 10:26","pubTimestamp":1739845560,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 诺诚健华(09969)早盘涨幅持续扩大,股价上涨9.85%,现报7.14港元,成交额4447.49万港元。\n 消息面上,诺诚健华发布公告,国家药品监督管理局(NMPA)药品审评中心(CDE)已批准在中国进行B细胞淋巴瘤-2 (BCL2)抑制剂ICP-248(Mesutoclax)联合 BTK抑制剂奥布替尼治疗一线慢性淋巴细胞白血病(CLL) ╱小淋巴细胞淋巴瘤 (SLL)患者的注册III期临床试验。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-18/doc-inekwkcq6916369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","BK1583","BK4134","03347","688428","III","BK6004","BK0239","5I4.SI","09969","BK1161","BK1576","BK1574","BK6512"],"gpt_icon":0},{"id":"2512974488","title":"江蘇長泰藥業股份有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2512974488","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512974488?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 07:20","pubTimestamp":1739834426,"startTime":"0","endTime":"0","summary":"金融界2月18日消息,据CDE官网沟通交流公示,于2月18日收到江苏长泰药业股份有限公司申请的“III类会议”,当前状态“处理中”。江苏长泰药业股份有限公司,成立于2010年,位于泰州市,是一家以从事医药制造业为主的企业。通过天眼查大数据分析,江苏长泰药业股份有限公司共对外投资了5家企业,参与招投标项目70次,知识产权方面有商标信息42条,专利信息120条,此外企业还拥有行政许可95个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/18072048212986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4134","III"],"gpt_icon":0},{"id":"2512974130","title":"大連美羅中藥廠有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2512974130","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512974130?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 07:20","pubTimestamp":1739834426,"startTime":"0","endTime":"0","summary":"大连美罗中药厂有限公司,成立于1999年,位于大连市,是一家以从事医药制造业为主的企业。通过天眼查大数据分析,大连美罗中药厂有限公司共对外投资了4家企业,参与招投标项目1714次,知识产权方面有商标信息4条,专利信息58条,此外企业还拥有行政许可200个。主要股东信息显示,大连美罗中药厂有限公司由美罗集团有限公司持股96.4095%、王格连持股3.5905%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/18072048212988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["III","BK4134"],"gpt_icon":0},{"id":"2512597448","title":"無錫朗潤醫藥有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2512597448","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512597448?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 07:20","pubTimestamp":1739834426,"startTime":"0","endTime":"0","summary":"金融界2月18日消息,据CDE官网沟通交流公示,于2月18日收到无锡朗润医药有限公司申请的“III类会议”,当前状态“处理中”。无锡朗润医药有限公司,成立于2019年,位于无锡市,是一家以从事研究和试验发展为主的企业。通过天眼查大数据分析,无锡朗润医药有限公司参与招投标项目2次,此外企业还拥有行政许可22个。主要股东信息显示,无锡朗润医药有限公司由江苏知原药业股份有限公司持股100%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/18072048212993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4134","BK1515","BK1161","III","BK1574","159938","09939"],"gpt_icon":0},{"id":"2512217942","title":"DeepSeek最新動作曝光,經營範圍新增互聯網信息服務!下一步向C端應用生態延伸?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512217942","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512217942?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 20:48","pubTimestamp":1739796530,"startTime":"0","endTime":"0","summary":"天眼查最新数据显示,国内AI独角兽DeepSeek关联公司——杭州深度求索人工智能基础技术研究有限公司近日完成工商信息重大调整。更值得关注的是,公司经营范围新增“互联网信息服务”资质,同步申请注册涵盖科学仪器、通讯服务、网站服务等领域的多枚图形商标。此次调整正值DeepSeek市场表现强劲之际。新增的互联网信息服务资质,结合图形商标布局,或预示其将从底层大模型研发向C端应用生态延伸。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/17204848208430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["160636","159792","III"],"gpt_icon":0},{"id":"2512194476","title":"諾誠健華(09969):BCL2抑制劑ICP-248(Mesutoclax)聯合奧布替尼用於一線CLL╱SLL患者治療的III期註冊研究在中國獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2512194476","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512194476?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 20:37","pubTimestamp":1739795870,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺诚健华 发布公告,国家药品监督管理局药品审评中心已批准在中国进行B细胞淋巴瘤-2 抑制剂ICP-248 联合 BTK抑制剂奥布替尼治疗一线慢性淋巴细胞白血病 ╱小淋巴细胞淋巴瘤 患者的注册III期临床试验。ICP248 通过选择性抑制BCL2蛋白,恢复肿瘤细胞正常凋亡,从而抑制肿瘤活性。ICP-248 联合奥布替尼治疗初治CLL/SLL患者在Ⅱ期临床试验中观察到良好的疗效和安全性,联合疗法上市将为初治CLL/SLL患者提供更佳治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","III","BK4134","09969","688428","BK1161","BK1574"],"gpt_icon":0},{"id":"2512166949","title":"DeepSeek新增互聯網信息服務","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166949","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512166949?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 19:32","pubTimestamp":1739791975,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 国家企业信用信息公示系统显示,推出 DeepSeek 大模型的杭州深度求索人工智能基础技术研究有限公司发生工商变更,经营范围新增互联网信息服务。另据天眼查 App 显示,该公司发生主要人员变更,裴湉由执行董事兼总经理改任董事、经理,新增王贤祖为财务负责人。(中国证券报)\n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/419262?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["161631","159792","160636","III","BK4134"],"gpt_icon":0},{"id":"2512949963","title":"諾誠健華獲批啓動ICP-248聯合療法III期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2512949963","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512949963?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 19:17","pubTimestamp":1739791037,"startTime":"0","endTime":"0","summary":"2月17日,诺诚健华(688428/09969)发布公告,近日公司自主研发的BCL2抑制剂ICP-248(Mesutoclax)联合BTK抑制剂奥布替尼治疗一线慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)已获得国家药品监督管理局(NMPA)药品审评中心(CDE)的批准,启动注册性III期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502173321226634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09969","BK1583","BK1141","BK4134","III","BK1574","BK1576","BK1161","03347"],"gpt_icon":0},{"id":"2512799778","title":"佛山市隆信醫藥科技有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2512799778","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512799778?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 14:20","pubTimestamp":1739773245,"startTime":"0","endTime":"0","summary":"佛山市隆信医药科技有限公司,成立于2007年,位于佛山市,是一家以从事科技推广和应用服务业为主的企业。通过天眼查大数据分析,佛山市隆信医药科技有限公司参与招投标项目2次,专利信息11条,此外企业还拥有行政许可6个。主要股东信息显示,佛山市隆信医药科技有限公司由广州市永信药业有限公司持股96.6667%、陈华兆持股3.3333%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/17142048197976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159938","BK1515","09939","BK4134","BK1574","III","BK1161"],"gpt_icon":0},{"id":"2512964112","title":"DeepSeek母公司主要人員變更,經營範圍擴大","url":"https://stock-news.laohu8.com/highlight/detail?id=2512964112","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512964112?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 09:41","pubTimestamp":1739756493,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4134","159792","III","160636","161631"],"gpt_icon":0},{"id":"2511677184","title":"【瀘天化:硝酸車間III硝裝置180天超長週期運行】 據瀘天化消息,自2024年8月19日19時05分開車以來,公司硝酸車間III硝裝置已連續平穩運行180天,累計生產硝酸6.8萬噸,創造了硝酸車間2025年首個長週期運行記錄。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511677184","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511677184?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 22:31","pubTimestamp":1739629872,"startTime":"0","endTime":"0","summary":"据泸天化消息,自2024年8月19日19时05分开车以来,公司硝酸车间III硝装置已连续平稳运行180天,累计生产硝酸6.8万吨,创造了硝酸车间2025年首个长周期运行记录。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15223148188605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0044","BK0004","BK0102","BK0066","BK0229","BK4134","III","BK0199","000912"],"gpt_icon":0},{"id":"2511678654","title":"【甘李藥業胰島素周製劑GZR4注射液中國2型糖尿病III期臨牀研究SUPER-2完成首例受試者給藥】 甘李藥業股份有限公司宣佈公司自主研發的基礎胰島素周製劑GZR4注射液在中國既往接受過基礎胰島素治療的2型糖尿病受試者中的開展的一項大規模III期臨牀研究完成首例受試者給藥,這也是甘李藥業啓動的GZR4注射液全球首項III期臨牀研究。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511678654","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511678654?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 16:48","pubTimestamp":1739609304,"startTime":"0","endTime":"0","summary":"甘李药业股份有限公司宣布公司自主研发的基础胰岛素周制剂GZR4注射液在中国既往接受过基础胰岛素治疗的2型糖尿病受试者中的开展的一项大规模III期临床研究完成首例受试者给药,这也是甘李药业启动的GZR4注射液全球首项III期临床研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15164848186811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","603087","BK4134","III"],"gpt_icon":0},{"id":"2511664902","title":"山東步長製藥股份有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2511664902","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511664902?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 07:51","pubTimestamp":1739577116,"startTime":"0","endTime":"0","summary":"金融界2月15日消息,据CDE官网沟通交流公示,于2月15日收到山东步长制药股份有限公司申请的“III类会议”,当前状态“处理中”。山东步长制药股份有限公司,成立于2001年,位于菏泽市,是一家以从事医药制造业为主的企业。通过天眼查大数据分析,山东步长制药股份有限公司共对外投资了63家企业,参与招投标项目5000次,知识产权方面有商标信息195条,专利信息85条,此外企业还拥有行政许可101个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/15075148179974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK4134","III","603858","BK0196"],"gpt_icon":0},{"id":"2511365712","title":"百時美施貴寶PD-1+LAG-3組合療法一項III期研究失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=2511365712","media":"医药魔方Info","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511365712?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 16:55","pubTimestamp":1739523355,"startTime":"0","endTime":"0","summary":"Opdualag是首个获得批准的PD-1+LAG-3组合抗体疗法,2022年3月,FDA批准该药用于治疗患有不可切除或转移性黑色素瘤的12岁及以上儿童和成人患者。临床前研究表明,抑制LAG-3可能促进抗肿瘤反应,同时抑制LAG-3和PD-1可能会增强某些癌症的抗肿瘤反应,从而使治疗效果优于PD-1单药治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214172812abceb7cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214172812abceb7cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242652126.USD","LU1670711040.USD","LU1291159041.SGD","LU1718418525.SGD","LU2242646821.SGD","LU1585245621.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","LU0321505868.SGD","PD","LU0306806265.USD","III","IE00BJT1NW94.SGD","LU0225771236.USD","LU1868837300.USD","LU1670711123.USD","BK4588","LU1074936037.SGD","LU1093756325.SGD","BK4559","LU1670710661.SGD","LU1430594728.SGD","LU2125154778.USD","IE00BSNM7G36.USD","LU1868837136.USD","BMY","LU0096364046.USD","LU1868836914.USD","LU2125154935.USD","LU0306807586.USD","BK4585","LU1868836757.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1261432733.SGD","LU0225284248.USD","BK4581","BK4532","LU0321505439.SGD","IE00B2B36J28.USD","BK4534","LU0882574055.USD","LU1169589451.USD","LU0985481810.HKD","LU2133065610.SGD","BK4023","LU1032466523.USD","LU0061475181.USD","LU1169590202.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2511548133","title":"金融信息服務巨頭,也來做VC了","url":"https://stock-news.laohu8.com/highlight/detail?id=2511548133","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511548133?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 18:51","pubTimestamp":1739443882,"startTime":"0","endTime":"0","summary":"每经记者 姚亚楠 每经编辑 肖芮冬金融信息服务巨头汤森路透也来做VC了。设基金、投项目,突破传统边界记者梳理发现,近年来,国内媒体集团和信息服务集团也在积极拓展CVC业务,以实现技术创新、业务拓展、战略协同等多元目标。清科研究中心统计显示,“双创浪潮”兴起以来,国内CVC投资案例数量和金额开始快速提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502131852479883f4c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502131852479883f4c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","LU1989763005.USD","BK4123","III","LU0757428866.USD","VC","IE00BZ199S13.USD","LU1989773731.SGD","BK4134","BK4579","BK4124","TRI"],"gpt_icon":0},{"id":"2511511918","title":"智翔金泰(688443.SH)GR1802注射液啓動慢性自發性蕁麻疹適應症III期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2511511918","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511511918?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 17:31","pubTimestamp":1739439091,"startTime":"0","endTime":"0","summary":"智通财经APP讯,智翔金泰(688443.SH)公告,公司就“一项评价GR1802注射液在慢性自发性荨麻疹患者中的有效性、安全性和免疫原性的随机、双盲、安慰剂对照、多中心III期临床试验”的开展,完成与国家药品监督管理局药品审评中心(CDE)EOP2(II期临床试验结束/III期临床试验启动前)的会议沟通,公司将正式启动该III期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1141","BK1583","BK4134","BK1576","688443","III","BK0239"],"gpt_icon":0},{"id":"2511951907","title":"智翔金泰:GR1802注射液啓動慢性自發性蕁麻疹III期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2511951907","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511951907?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 17:28","pubTimestamp":1739438883,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["03347","688443","BK0239","BK4134","III","BK1583","BK1141","BK1576"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2025-07-10","symbol":"III","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1752134400000,"name":null,"time":"盤前","dateTimestamp":1752120000000,"actualEps":null},{"date":"2025-06-06","symbol":"III","amount":0.045,"announcedDate":"2025-05-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-06","defaultRemindTime":1749216600000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-06","currency":"USD","dateTimestamp":1749182400000,"payDate":"2025-06-27"},{"market":"US","date":"2025-05-08","symbol":"III","fiscalQuarterEnding":"2025/03","expectedEps":0.04,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.04},{"date":"2025-03-21","symbol":"III","amount":0.045,"announcedDate":"2025-03-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"market":"US","date":"2025-03-06","symbol":"III","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2025-05-15","current":30.924138,"percent":0.651503,"low":-221.876594,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"high":85.733259,"avg":5.507339,"sd":61.612714,"marketCap":238610651},"quantilePoints":[{"date":"2020-05-22","current":28.776145,"twenty":20.050829,"median":32.183452,"eighty":49.624683,"marketCap":82846522},{"date":"2020-05-29","current":28.445385,"twenty":20.050829,"median":32.145891,"eighty":49.624683,"marketCap":81894263},{"date":"2020-06-05","current":35.060591,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100939441},{"date":"2020-06-12","current":33.406789,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":96178146},{"date":"2020-06-19","current":33.241409,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":95702017},{"date":"2020-06-26","current":33.90293,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":97606535},{"date":"2020-07-02","current":35.556731,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":102367829},{"date":"2020-07-10","current":34.23369,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":98558794},{"date":"2020-07-17","current":34.23369,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":98558794},{"date":"2020-07-24","current":33.57217,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":96654276},{"date":"2020-07-31","current":33.90293,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":97606535},{"date":"2020-08-07","current":35.060591,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100939441},{"date":"2020-08-14","current":36.396194,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":112027485},{"date":"2020-08-21","current":34.990332,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":107700243},{"date":"2020-08-28","current":32.491023,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100007369},{"date":"2020-09-04","current":33.272057,"twenty":20.050829,"median":32.145891,"eighty":49.624683,"marketCap":102411392},{"date":"2020-09-11","current":32.100506,"twenty":20.050829,"median":32.155221,"eighty":49.624683,"marketCap":98805357},{"date":"2020-09-18","current":33.896885,"twenty":20.050829,"median":32.150556,"eighty":49.624683,"marketCap":104334611},{"date":"2020-09-25","current":32.178609,"twenty":20.050829,"median":32.143037,"eighty":49.624683,"marketCap":99045759},{"date":"2020-10-02","current":32.64723,"twenty":20.050829,"median":32.150556,"eighty":49.624683,"marketCap":100488173},{"date":"2020-10-09","current":33.584471,"twenty":20.050829,"median":32.166915,"eighty":49.624683,"marketCap":103373001},{"date":"2020-10-16","current":32.803437,"twenty":20.050829,"median":32.195146,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-23","current":32.803437,"twenty":20.050829,"median":32.271873,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-30","current":32.022403,"twenty":20.050829,"median":32.29645,"eighty":49.624683,"marketCap":98564955},{"date":"2020-11-06","current":37.645849,"twenty":20.050829,"median":32.334816,"eighty":49.624683,"marketCap":115873923},{"date":"2020-11-13","current":37.83975,"twenty":20.050829,"median":32.470567,"eighty":49.624683,"marketCap":128692991},{"date":"2020-11-20","current":37.698557,"twenty":20.050829,"median":32.551135,"eighty":49.624683,"marketCap":128212793},{"date":"2020-11-27","current":45.040598,"twenty":20.050829,"median":32.61356,"eighty":49.624683,"marketCap":153183075},{"date":"2020-12-04","current":44.052247,"twenty":20.055618,"median":32.732778,"eighty":49.624683,"marketCap":149821691},{"date":"2020-12-11","current":44.617019,"twenty":20.096237,"median":32.786479,"eighty":49.624683,"marketCap":151742482},{"date":"2020-12-18","current":46.170143,"twenty":20.444658,"median":32.803437,"eighty":49.624683,"marketCap":157024657},{"date":"2020-12-24","current":42.781509,"twenty":20.563355,"median":32.855737,"eighty":49.624683,"marketCap":145499912},{"date":"2020-12-31","current":46.311336,"twenty":20.775561,"median":32.958394,"eighty":49.624683,"marketCap":157504855},{"date":"2021-01-08","current":49.417585,"twenty":21.565226,"median":33.007951,"eighty":49.624683,"marketCap":168069205},{"date":"2021-01-15","current":55.771274,"twenty":21.971704,"median":33.076029,"eighty":50.098483,"marketCap":189678103},{"date":"2021-01-22","current":50.829515,"twenty":22.396936,"median":33.127057,"eighty":50.207132,"marketCap":172871182},{"date":"2021-01-29","current":49.841164,"twenty":22.679784,"median":33.261363,"eighty":50.440112,"marketCap":169509798},{"date":"2021-02-05","current":52.523833,"twenty":22.936122,"median":33.272057,"eighty":50.716561,"marketCap":178633555},{"date":"2021-02-12","current":52.523833,"twenty":23.262797,"median":33.398429,"eighty":51.059228,"marketCap":178633555},{"date":"2021-02-19","current":53.794571,"twenty":23.609141,"median":33.417527,"eighty":51.276882,"marketCap":182955335},{"date":"2021-02-26","current":51.394288,"twenty":23.816947,"median":33.569725,"eighty":51.732235,"marketCap":174791973},{"date":"2021-03-05","current":53.088605,"twenty":24.140202,"median":33.57217,"eighty":51.962271,"marketCap":180554346},{"date":"2021-03-12","current":77.651845,"twenty":24.664612,"median":33.630766,"eighty":52.202094,"marketCap":213930833},{"date":"2021-03-19","current":71.502943,"twenty":26.272494,"median":33.737549,"eighty":52.523833,"marketCap":196990608},{"date":"2021-03-26","current":76.77343,"twenty":26.854371,"median":33.859576,"eighty":52.626372,"marketCap":211510801},{"date":"2021-04-01","current":78.003211,"twenty":26.956092,"median":33.90293,"eighty":52.747595,"marketCap":214898846},{"date":"2021-04-09","current":75.895016,"twenty":27.210395,"median":33.991802,"eighty":52.906055,"marketCap":209090769},{"date":"2021-04-16","current":76.422065,"twenty":27.379781,"median":34.193624,"eighty":53.109266,"marketCap":210542788},{"date":"2021-04-23","current":77.124796,"twenty":27.464698,"median":34.23369,"eighty":53.271145,"marketCap":212478813},{"date":"2021-04-30","current":79.935723,"twenty":27.596809,"median":34.39907,"eighty":53.663807,"marketCap":220222916},{"date":"2021-05-07","current":85.733259,"twenty":27.758845,"median":34.72983,"eighty":53.929654,"marketCap":236195128},{"date":"2021-05-14","current":34.582604,"twenty":27.90985,"median":34.72983,"eighty":53.929654,"marketCap":260718251},{"date":"2021-05-21","current":37.193814,"twenty":27.984267,"median":34.89521,"eighty":53.929654,"marketCap":280404160},{"date":"2021-05-28","current":37.32119,"twenty":28.127158,"median":35.060591,"eighty":53.929654,"marketCap":281364448},{"date":"2021-06-04","current":35.665301,"twenty":28.201568,"median":35.178625,"eighty":53.929654,"marketCap":268880701},{"date":"2021-06-11","current":36.811685,"twenty":28.275979,"median":35.34686,"eighty":53.929654,"marketCap":277523295},{"date":"2021-06-18","current":35.283172,"twenty":28.317177,"median":35.460054,"eighty":53.929654,"marketCap":265999836},{"date":"2021-06-25","current":35.983741,"twenty":28.42477,"median":35.600769,"eighty":53.929654,"marketCap":271281422},{"date":"2021-07-02","current":38.27651,"twenty":28.559204,"median":35.741483,"eighty":53.929654,"marketCap":288566610},{"date":"2021-07-09","current":38.212822,"twenty":28.661781,"median":35.920053,"eighty":53.929654,"marketCap":288086466},{"date":"2021-07-16","current":36.174805,"twenty":28.841499,"median":36.238493,"eighty":53.929654,"marketCap":272721854},{"date":"2021-07-23","current":38.085446,"twenty":29.02216,"median":36.365869,"eighty":53.929654,"marketCap":287126177},{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-17","current":62.889768,"twenty":12.590422,"median":18.990743,"eighty":34.814432,"marketCap":178544051},{"date":"2025-04-25","current":62.379851,"twenty":12.589786,"median":18.928478,"eighty":34.943677,"marketCap":177096396},{"date":"2025-05-02","current":64.589491,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":183369566},{"date":"2025-05-09","current":25.015629,"twenty":12.589786,"median":18.928478,"eighty":35.046539,"marketCap":193020596},{"date":"2025-05-15","current":30.924138,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":238610651}],"updateTime":1747402832676}}}